tobramycin has been researched along with Disease Exacerbation in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.35) | 29.6817 |
| 2010's | 19 (82.61) | 24.3611 |
| 2020's | 3 (13.04) | 2.80 |
| Authors | Studies |
|---|---|
| Albright, JC; Houck, AP; Pettit, RS | 1 |
| Fernández-Trujillo, L; Morales, EI; Sangiovanni, S | 1 |
| Abdel, MP; Berry, DJ; Dagneaux, L; Leung, N; Limberg, AK; Osmon, DR | 1 |
| Deka, R; Hong, LT; King, JB; Liou, TG; Stevens, V; Young, DC | 1 |
| Charbek, E; Rowbotham, NJ; Smith, S | 1 |
| Cogen, JD; Goss, CH; Nichols, DP; Nick, JA; Nick, SE; Russell, R; Saavedra, MT; Somayaji, R; Taylor-Cousar, JL | 1 |
| Klingel, M; Ratjen, F; Stanojevic, S; Tullis, E; Waters, V | 1 |
| Kemper, AL; Young, DC; Zobell, JT | 1 |
| Ampofo, K; Sherwin, CM; Spigarelli, MG; Stockmann, C; Waters, CD; Young, DC; Zobell, JT | 1 |
| Al-Aloul, M; Nazareth, D; Walshaw, M | 1 |
| Cantrell, A; Carroll, C; Harnan, S; Mildred, M; Tappenden, P; Uttley, L | 1 |
| Brownlee, K; Cantrell, A; Harnan, S; Tappenden, P; Taylor, C; Uttley, L; Walshaw, M | 1 |
| Prescott, WA | 1 |
| Accurso, FJ; Ajayi, T; Barth, J; Branstrom, A; Bronsveld, I; De Boeck, K; Elborn, JS; Elfring, GL; Fajac, I; Kerem, E; Knoop, C; Konstan, MW; Malfroot, A; McColley, SA; Melotti, P; Peltz, SW; Quattrucci, S; Rietschel, E; Rosenbluth, DB; Rowe, SM; Sermet-Gaudelus, I; Spiegel, RJ; Walker, PA; Welch, EM; Wilschanski, M; Zeitlin, PL | 1 |
| Bos, AC; Devadason, S; Janssens, HM; Mouton, JW; Tiddens, HA | 1 |
| Aslam, AA; Higgins, C; Sinha, IP; Southern, KW | 1 |
| Accurso, FJ; Harris, JK; Sagel, SD; Wagener, JS; Wagner, BD; Zemanick, ET | 1 |
| Brown, R; Sacco, P; Woodward, TC; Zhang, J | 1 |
| Adeboyeku, D; Hodson, ME; Jones, AL | 1 |
| Angyalosi, G; Balp, MM; Capkun-Niggli, G; Doering, G; Higashi, K; Jansen, JP; Littlewood, KJ; Tiddens, HA | 1 |
| Brokalaki, EI; Hillen, U; Sommerwerck, U; von Heinegg, EH | 1 |
| Jahnke, N; Remmington, T; Ryan, G | 1 |
| Blumer, JL; Konstan, MW; Melnick, D; Saiman, L | 1 |
9 review(s) available for tobramycin and Disease Exacerbation
| Article | Year |
|---|---|
Inhaled tobramycin for chronic infection with pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis.
Topics: Administration, Inhalation; Bronchiectasis; Chronic Disease; Disease Progression; Female; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Tobramycin; Treatment Outcome | 2021 |
Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Cystic Fibrosis; Disease Progression; Forced Expiratory Volume; Humans; Injections, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Ticarcillin; Tobramycin | 2018 |
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. Aminoglycosides.
Topics: Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Child; Cystic Fibrosis; Disease Progression; Gentamicins; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2013 |
Colistimethate sodium powder and tobramycin powder for inhalation for the treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis: systematic review and economic model.
Topics: Administration, Inhalation; Child; Colistin; Cost-Benefit Analysis; Cystic Fibrosis; Disease Progression; Humans; Outcome Assessment, Health Care; Pseudomonas aeruginosa; Pseudomonas Infections; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Therapeutic Equivalency; Tobramycin; United Kingdom | 2013 |
Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Colistin; Cystic Fibrosis; Disease Progression; Dry Powder Inhalers; Evidence-Based Medicine; Forced Expiratory Volume; Humans; Lung; Powders; Pseudomonas aeruginosa; Pseudomonas Infections; Research Design; Time Factors; Tobramycin; Treatment Outcome | 2013 |
Inhaled antibiotics: dry or wet?
Topics: Administration, Inhalation; Aerosols; Anti-Bacterial Agents; Aztreonam; Colistin; Cystic Fibrosis; Disease Progression; Dry Powder Inhalers; Humans; Nebulizers and Vaporizers; Pseudomonas aeruginosa; Tobramycin | 2014 |
Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Codon, Nonsense; Cystic Fibrosis; Disease Progression; Female; Humans; Male; Middle Aged; Oxadiazoles; Quality of Life; Randomized Controlled Trials as Topic; Tobramycin | 2017 |
A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis.
Topics: Administration, Inhalation; Adolescent; Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Load; Bayes Theorem; Biological Availability; Chronic Disease; Colistin; Cystic Fibrosis; Disease Progression; Female; Forced Expiratory Volume; Humans; Information Services; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Tobramycin; Treatment Outcome | 2012 |
Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Cystic Fibrosis; Disease Progression; Humans; Injections, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Ticarcillin; Tobramycin | 2012 |
4 trial(s) available for tobramycin and Disease Exacerbation
| Article | Year |
|---|---|
Nebulized tobramycin in the treatment of adult CF pulmonary exacerbations.
Topics: Administration, Inhalation; Adolescent; Adult; Anti-Bacterial Agents; Cross-Over Studies; Cystic Fibrosis; Disease Progression; England; Female; Humans; Injections, Intravenous; Kidney; Lung; Male; Nebulizers and Vaporizers; Pilot Projects; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Sputum; Time Factors; Tobramycin; Treatment Outcome; Young Adult | 2014 |
Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial.
Topics: Acute Kidney Injury; Adolescent; Adult; Anti-Bacterial Agents; Child; Chlorides; Codon, Nonsense; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Progression; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Oxadiazoles; Sweat; Tobramycin; Young Adult | 2014 |
Twice vs three-times daily antibiotics in the treatment of pulmonary exacerbations of cystic fibrosis.
Topics: Adult; Anti-Bacterial Agents; Ceftazidime; Cystic Fibrosis; Disease Progression; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Ear Diseases; Female; Humans; Injections, Intravenous; Kidney Diseases; Lung; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Function Tests; Tobramycin; Treatment Outcome | 2011 |
The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Burkholderia cepacia; Burkholderia Infections; Ceftazidime; Child; Child, Preschool; Cystic Fibrosis; Disease Progression; Drug Therapy, Combination; Forced Expiratory Volume; Humans; Meropenem; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Function Tests; Sputum; Thienamycins; Tobramycin | 2005 |
10 other study(ies) available for tobramycin and Disease Exacerbation
| Article | Year |
|---|---|
Effects of CFTR modulators on pharmacokinetics of tobramycin during acute pulmonary exacerbations in the pediatric cystic fibrosis population.
Topics: Administration, Intravenous; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Progression; Drug Interactions; Female; Humans; Male; Tobramycin | 2020 |
Acute Kidney Injury When Treating Periprosthetic Joint Infections After Total Knee Arthroplasties with Antibiotic-Loaded Spacers: Incidence, Risks, and Outcomes.
Topics: Acute Kidney Injury; Administration, Oral; Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Bone Cements; Creatinine; Disease Progression; Drug Implants; Female; Follow-Up Studies; Gentamicins; Humans; Incidence; Injections, Intravenous; Male; Middle Aged; Odds Ratio; Prosthesis-Related Infections; Renal Insufficiency, Chronic; Retrospective Studies; Risk; Risk Factors; Tobramycin; Treatment Outcome; Vancomycin | 2021 |
Pharmacokinetics of Continuous Infusion Beta-lactams in the Treatment of Acute Pulmonary Exacerbations in Adult Patients With Cystic Fibrosis.
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Cystic Fibrosis; Disease Progression; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Retrospective Studies; Symptom Flare Up; Tobramycin | 2018 |
Oral Azithromycin Use and the Recovery of Lung Function from Pulmonary Exacerbations Treated with Intravenous Tobramycin or Colistimethate in Adults with Cystic Fibrosis.
Topics: Administration, Inhalation; Administration, Intravenous; Adult; Anti-Bacterial Agents; Azithromycin; Colistin; Cystic Fibrosis; Disease Progression; Female; Forced Expiratory Volume; Humans; Logistic Models; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tobramycin; Young Adult | 2019 |
Oral Azithromycin and Response to Pulmonary Exacerbations Treated with Intravenous Tobramycin in Children with Cystic Fibrosis.
Topics: Administration, Intravenous; Adolescent; Anti-Bacterial Agents; Azithromycin; Child; Cystic Fibrosis; Disease Progression; Female; Forced Expiratory Volume; Humans; Logistic Models; Male; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2019 |
The use of doripenem in pediatric cystic fibrosis patients in case of meropenem shortages.
Topics: Adolescent; Anti-Bacterial Agents; Burkholderia cenocepacia; Burkholderia Infections; Carbapenems; Child; Cystic Fibrosis; Disease Progression; Doripenem; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Pseudomonas stutzeri; Rhodospirillaceae; Thienamycins; Tobramycin; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.
Topics: Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cystic Fibrosis; Disease Progression; Drug Administration Schedule; Drug Monitoring; Gentamicins; Health Care Surveys; Humans; Middle Aged; Practice Guidelines as Topic; Practice Patterns, Physicians'; Tobramycin; United States | 2014 |
Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Bronchoalveolar Lavage Fluid; Child; Cystic Fibrosis; Disease Progression; Female; Humans; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Sputum; Tobramycin; Young Adult | 2010 |
Budget impact model of tobramycin inhalation solution for treatment of Pseudomonas aeruginosa in cystic fibrosis patients.
Topics: Administration, Inhalation; Adolescent; Anti-Bacterial Agents; Child; Cystic Fibrosis; Disease Progression; Female; Humans; Male; Managed Care Programs; Models, Economic; Patient Admission; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; United States | 2010 |
Ochroconis gallopavum infection in a lung transplant recipient: report of a case.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Biopsy; Bronchiolitis Obliterans; Disease Progression; Drug Administration Schedule; Enterobacter cloacae; Enterococcus; Fatal Outcome; Humans; Imipenem; Lung Transplantation; Male; Opportunistic Infections; Phaeohyphomycosis; Pyrimidines; Respiratory Tract Infections; Skin; Sputum; Tobramycin; Treatment Outcome; Triazoles; Voriconazole | 2012 |